Resources

Benefits of quitting Smoking
1
When people give up smoking, they experience a range of short, medium-term health benefits6
2
In a few days, heart rate drops, sense of smell and taste improves, and blood levels of carbon monoxide and oxygen return to normal
3
In a few weeks, their risk of sudden death from a heart attack is reduced, their lung function improves, and they are less short of breath
4
In a few months, their symptoms of chronic bronchitis improve, and they are at reduced risk of ulcers1
References
  1. HSE (Health Service Executive). Tobacco Free Ireland Annual Report 2022. Available at: https://www.hse.ie/eng/about/who/tobaccocontrol/tfi-annual-report-2022.pdf [Accessed: July, 2025].
  2. Department of Health. Economic and social cost of smoking in Ireland. Dublin: Department of Health, 2022. Available at: https://www.gov.ie/en/publication/5d2c8-economic-and-social-cost-of-smoking-in-ireland/ [Accessed: July, 2025].
  3. Ipsos B&A. (2023) Healthy Ireland survey 2023 – summary report. Dublin: Healthy Ireland, Department of Health. Available at: https://www.drugsandalcohol.ie/39977/ (Accessed July 2025)
  4. Healthy Ireland Survey 2021. Summary Report. Department of Health, 2021. Available at: https://www.gov.ie/en/publication/9ef45-healthy-ireland-survey-2021/ [Accessed: July, 2025].
  5. HSE Smoking facts and figures. Availabel at https://www2.hse.ie/living-well/quit-smoking/reasons-to-quit/facts-and-figures/ (Accessed July 2025)
  6. NHS Inform. Benefits of stopping smoking. Available at https://www.nhsinform.scot/healthy-living/stopping-smoking/reasons-to-stop/benefits-of-stopping-smoking/. Accessed July 2025.
Safety Profile
Get an overview of the safety data and tolerability of Citidaron.
Taking Citidaron
See the step-by-step course for taking Citidaron
Resources for you
Find additional support and information to help your patients succeed

Adverse events should be reported. Reporting forms and information are available from HPRA Pharmacovigilance on the HPRA website www.hpra.ie. Adverse events should also be reported to Consilient Health at drugsafety@consilienthealth.com or 012057766.

The information on this website is intended for Health Care Professional who practice in the Republic of Ireland only

Sign up to stay informed about upcoming webinars

IE-CH-1738, September 2025